Literature DB >> 16690937

NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner.

Lin Deng1, Motoko Nagano-Fujii, Motofumi Tanaka, Yuki Nomura-Takigawa, Masanori Ikeda, Nobuyuki Kato, Kiyonao Sada, Hak Hotta.   

Abstract

The N-terminal 198 residues of NS3 (NS3-N) of Hepatitis C virus (HCV) subtype 1b obtained from 29 patients, as well as full-length NS3 (NS3-Full), were analysed for their subcellular localization, interaction with the tumour suppressor p53 and serine protease activity in the presence and absence of the viral cofactor NS4A. Based on the subcellular-localization patterns in the absence of NS4A, NS3-N sequences were classified into three groups, with each group exhibiting either dot-like, diffuse or a mixed type of localization. Chimeric NS3-Full sequences, each consisting of an individual NS3-N and a shared C-terminal sequence, showed the same localization patterns as those of the respective NS3-N. Site-directed mutagenesis experiments revealed that a single or a few amino acid substitutions at a particular position(s) of NS3-N altered the localization pattern. Interestingly, NS3 of the dot-like type, either NS3-N or NS3-Full, interacted with p53 more strongly than that of the diffuse type, in both the presence and the absence of NS4A. Moreover, NS3-N of the dot-like type suppressed trans-activating activity of p53 more strongly than that of the diffuse type. Serine protease activity did not differ significantly between the two types of NS3. In HCV RNA replicon-harbouring cells, physical interaction between NS3 and p53 was observed consistently and p53-mediated transcriptional activation was suppressed significantly compared with HCV RNA-negative control cells. Our results collectively suggest the possibility that NS3 plays an important role in the hepatocarcinogenesis of HCV by interacting differentially with p53 in an NS3 sequence-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690937     DOI: 10.1099/vir.0.81735-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  39 in total

Review 1.  The role of cirrhosis in the etiology of hepatocellular carcinoma.

Authors:  Michael C Kew
Journal:  J Gastrointest Cancer       Date:  2014-03

Review 2.  Common threads in persistent viral infections.

Authors:  Melissa Kane; Tatyana Golovkina
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

Review 3.  Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Authors:  Amir Shlomai; Ype P de Jong; Charles M Rice
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

4.  Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.

Authors:  Lin Deng; Xiang Gan; Masahiko Ito; Ming Chen; Hussein H Aly; Chieko Matsui; Takayuki Abe; Koichi Watashi; Takaji Wakita; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura; Masashi Mizokami; Ikuo Shoji; Hak Hotta
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

5.  Hepatitis C Virus NS3 Protein Plays a Dual Role in WRN-Mediated Repair of Nonhomologous End Joining.

Authors:  Tsu-I Chen; Yuan-Kai Hsu; Chia-Yi Chou; Yu-Hsin Chen; Shing-Tzu Hsu; Yan-Shuo Liou; Yu-Ching Dai; Ming-Fu Chang; Shin C Chang
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

Review 6.  Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.

Authors:  Yujin Hoshida; Bryan C Fuchs; Nabeel Bardeesy; Thomas F Baumert; Raymond T Chung
Journal:  J Hepatol       Date:  2014-11-03       Impact factor: 25.083

Review 7.  Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer.

Authors:  D R McGivern; S M Lemon
Journal:  Oncogene       Date:  2011-01-24       Impact factor: 9.867

Review 8.  Viral hepatocarcinogenesis.

Authors:  W-L Tsai; R T Chung
Journal:  Oncogene       Date:  2010-03-15       Impact factor: 9.867

Review 9.  Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.

Authors:  David R McGivern; Stanley M Lemon
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

Review 10.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.